ABBOTT LABORATORIES — Director's Dealing 2018

Feb 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-02-20

Reporting Person: Fussell Stephen R (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-20	Common shares without par value	S	200	$59.82	Disposed	190216	Direct
2018-02-20	Common shares without par value	S	1832	$59.83	Disposed	188384	Direct
2018-02-20	Common shares without par value	S	1100	$59.84	Disposed	187284	Direct
2018-02-20	Common shares without par value	S	1000	$59.85	Disposed	186284	Direct
2018-02-20	Common shares without par value	S	400	$59.855	Disposed	185884	Direct
2018-02-20	Common shares without par value	S	100	$59.8575	Disposed	185784	Direct
2018-02-20	Common shares without par value	S	900	$59.86	Disposed	184884	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1599	Indirect
Common shares without par value	53	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 16, 2018.

F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.